AMRI : Summary for Albany Molecular Research, Inc. - Yahoo Finance

U.S. Markets closed

Albany Molecular Research, Inc. (AMRI)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.23-0.16 (-0.98%)
At close: 4:00 PM EST
People also watch:
ARQLARRYALKSENZNANIK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close16.39
Open16.39
Bid0.00 x
Ask0.00 x
Day's Range16.15 - 16.57
52 Week Range12.45 - 20.59
Volume178,846
Avg. Volume235,869
Market Cap584.54M
Beta1.01
PE Ratio (TTM)-11.11
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : AMRI-US : December 2, 2016
    Capital Cube17 hours ago

    Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : AMRI-US : December 2, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Albany Molecular Research, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day ... Read more (Read more...)

  • PR Newswire4 days ago

    AMRI Announces API Supply Agreement with Shire

    ALBANY, N.Y., Nov. 29, 2016 /PRNewswire/ -- AMRI (AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, Inc. which product has been in AMRI's portfolio through the required stages of development.  Shire plc, is a leading global biotechnology company focused on developing and marketing innovative medicines for patients with rare diseases and other highly specialized conditions. The terms of the agreement are confidential.  This is the second such multi-year agreement between AMRI and Shire, as AMRI has also been supplying a key neuroscience product to Shire. "This agreement builds on the long-standing development and manufacturing relationship between Shire and AMRI," said William S. Marth, President and CEO of AMRI.

  • Capital Cube5 days ago

    ETFs with exposure to Albany Molecular Research, Inc. : November 28, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Albany Molecular Research, Inc. Here are 5 ETFs with the largest exposure to AMRI-US. Comparing the performance and risk of Albany Molecular Research, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)